Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Seminars in Oncology
|
May 5, 2004
An update on the management of relapsed and primary refractory Hodgkin's disease
Craig Moskowitz
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma
Craig Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
April 10, 2015
Highlights in lymphoma from the 12th International Conference on Malignant Lymphoma: commentary
Craig Moskowitz
Best Practice & Research. Clinical Haematology
|
March 14, 2012
Diffuse large B cell lymphoma: how can we cure more patients in 2012?
Craig Moskowitz
Cancer Chemotherapy and Pharmacology
|
June 4, 2002
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
Craig Moskowitz
Radiologic Clinics of North America
|
July 16, 2008
PET imaging for response assessment in lymphoma: potential and limitations
Heiko Schöder, Craig Moskowitz
Cancer Treatment and Research
|
September 26, 2009
The role of hematopoietic stem cell transplantation in Hodgkin lymphoma
Craig Moskowitz, John Sweetenham
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Metabolic Tumor Volume in Lymphoma: Hype or Hope?
Heiko Schöder, Craig Moskowitz
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 24, 2012
Controversies in BMT for lymphoma
Randy D Gascoyne, Craig Moskowitz, Thomas C Shea
Heartrhythm Case Reports
|
June 9, 2025
Procainamide-facilitated induction of Purkinje premature ventricular contractions in a patient with idiopathic ventricular fibrillation
Mai Badr, Sindhuja Palle, Craig Moskowitz, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Seminars in Oncology
|
May 5, 2004
An update on the management of relapsed and primary refractory Hodgkin's disease
Craig Moskowitz
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma
Craig Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
April 10, 2015
Highlights in lymphoma from the 12th International Conference on Malignant Lymphoma: commentary
Craig Moskowitz
Best Practice & Research. Clinical Haematology
|
March 14, 2012
Diffuse large B cell lymphoma: how can we cure more patients in 2012?
Craig Moskowitz
Cancer Chemotherapy and Pharmacology
|
June 4, 2002
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
Craig Moskowitz
Radiologic Clinics of North America
|
July 16, 2008
PET imaging for response assessment in lymphoma: potential and limitations
Heiko Schöder, Craig Moskowitz
Cancer Treatment and Research
|
September 26, 2009
The role of hematopoietic stem cell transplantation in Hodgkin lymphoma
Craig Moskowitz, John Sweetenham
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Metabolic Tumor Volume in Lymphoma: Hype or Hope?
Heiko Schöder, Craig Moskowitz
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 24, 2012
Controversies in BMT for lymphoma
Randy D Gascoyne, Craig Moskowitz, Thomas C Shea
Heartrhythm Case Reports
|
June 9, 2025
Procainamide-facilitated induction of Purkinje premature ventricular contractions in a patient with idiopathic ventricular fibrillation
Mai Badr, Sindhuja Palle, Craig Moskowitz, et al.
Page
of 4